fully integrated and automated control hardware and software (Nanopoint Inc)
90
Structured Review
Nanopoint Inc
fully integrated and automated control hardware and software
Fully Integrated And Automated Control Hardware And Software, supplied by Nanopoint Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fully+integrated+and+automated+control+hardware+and+software/fully+integrated+and+automated+control+hardware+and+software/pm20832352-101-14-6
Average 90 stars, based on 1 article reviews
Fully Integrated And Automated Control Hardware And Software, supplied by Nanopoint Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fully+integrated+and+automated+control+hardware+and+software/fully+integrated+and+automated+control+hardware+and+software/pm20832352-101-14-6
Average 90 stars, based on 1 article reviews
fully integrated and automated control hardware and software - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Control:Article Title: Tumors on chips: oncology meets microfluidics. Article Snippet: Despite over 2 million papers published on cancer so far, malignancy still remains a puzzlingly complex disease with overall low survival rates.. Expanding our knowledge of the molecular mechanisms of malignancy and of resistance to therapy is crucial in guiding the successful design of anticancer drugs and new point-of-care diagnostics.. The up-andcoming microfluidic Lab-on-a-Chip (LOC) technology and micro-total analysis systems (mTAS) are arguably the most promising platforms to address the inherent complexity of cellular systems with massive experimental parallelization and 4D analysis on a single cell level. Software:Article Title: Tumors on chips: oncology meets microfluidics. Article Snippet: Despite over 2 million papers published on cancer so far, malignancy still remains a puzzlingly complex disease with overall low survival rates.. Expanding our knowledge of the molecular mechanisms of malignancy and of resistance to therapy is crucial in guiding the successful design of anticancer drugs and new point-of-care diagnostics.. The up-andcoming microfluidic Lab-on-a-Chip (LOC) technology and micro-total analysis systems (mTAS) are arguably the most promising platforms to address the inherent complexity of cellular systems with massive experimental parallelization and 4D analysis on a single cell level. |